Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. | Sci Rep | 2020 | 33384440 | PubTator, text mining | PubMed |
| Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia. | Asian Pac J Cancer Prev | 2020 | 33369472 | PubTator, text mining | PubMed |
| How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing? | Front Genet | 2020 | 33363564 | PubTator, text mining | PubMed |
| Food Implications in Central Sensitization Syndromes. | J Clin Med | 2020 | 33352747 | PubTator, text mining | PubMed |
| Cytokines and Their Genetic Polymorphisms Related to Periodontal Disease. | J Clin Med | 2020 | 33327639 | PubTator, text mining | PubMed |
| Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. | Biomolecules | 2020 | 33327600 | PubTator, text mining | PubMed |
| Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. | Cell Rep | 2020 | 33296651 | PubTator, text mining | PubMed |
| Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations. | Sci Rep | 2020 | 33277594 | PubTator, text mining | PubMed |
| Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line. | Cells | 2020 | 33260628 | PubTator, text mining | PubMed |
| Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis. | PLoS One | 2020 | 33237904 | PubTator, text mining | PubMed |
| SMO mutations confer poor prognosis in malignant pleural mesothelioma. | Transl Lung Cancer Res | 2020 | 33209614 | PubTator, text mining | PubMed |
| Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer. | Aging (Albany NY) | 2020 | 33203797 | PubTator, text mining | PubMed |
| Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma. | Aging (Albany NY) | 2020 | 33188160 | PubTator, text mining | PubMed |
| Impact of Gene-Environment Interactions on Cancer Development. | Int J Environ Res Public Health | 2020 | 33153024 | PubTator, text mining | PubMed |
| Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation. | Sci Rep | 2020 | 33144648 | PubTator, text mining | PubMed |
| A Review of the Important Role of CYP2D6 in Pharmacogenomics. | Genes (Basel) | 2020 | 33143137 | PubTator, text mining | PubMed |
| Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis. | Antimicrob Agents Chemother | 2020 | 33139294 | PubTator, text mining | PubMed |
| The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand. | Tuberc Respir Dis (Seoul) | 2020 | 33138342 | PubTator, text mining | PubMed |
| Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia. | Saudi Pharm J | 2020 | 33132716 | PubTator, text mining | PubMed |
| Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population. | Medicine (Baltimore) | 2020 | 33126298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=39